Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs

  • Post author:
  • Post category:

Research Objective The candidate is a fixed dose binary small molecule drug combination, consisting of two agents that act synergistically on a multipotent stem cell population in the CNS to…

Continue ReadingImproving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs